|Nombre||Título||Pagar||Ejecutado||Año de nacimiento|
|Mr. Paul Hudson||CEO & Director||5.63M||N/D||1967|
|Mr. Jean-Baptiste Chasseloup de Chatillon||Exec. VP & CFO||N/D||N/D||1965|
|Mr. Laurent Gilhodes||Principal Accounting Officer and VP of Corp. Accounting||N/D||N/D||N/D|
|Mr. Bruno MÃ©nard||Chief Information officer||N/D||N/D||N/D|
|Dr. Josephine Fubara||Chief Science Officer of Consumer Health Care||N/D||N/D||N/D|
|Mr. George Grofik C.F.A., CPA, CFA||Head of Investor Relations||N/D||N/D||N/D|
|Ms. Karen Linehan||Exec. VP of Legal Affairs & Gen. Counsel||N/D||N/D||1959|
|Mr. Dante Beccaria||Global Compliance Officer & VP||N/D||N/D||N/D|
|Mr. Josep Catlla||Head of Communications||N/D||N/D||N/D|
|Mr. Pierre Chancel||Sr. VP of Global Diabetes and Sr. VP of Global Marketing||N/D||N/D||1957|
Sanofi provides therapeutic solutions worldwide. It offers Cerezyme and Cerdelga for Gaucher, Myozyme and Lumizyme for Pompe, Fabrazyme for Fabry, and Aldurazyme for mucopolysaccharidosis Type 1; and Aubagio and Lemtrada for multiple sclerosis. It also provides Dupixent for atopic dermatitis; Kevzara for rheumatoid arthritis; Eloctate and Alprolix to treat hemophilia; and Cablivi to treat acquired thrombotic thrombocytopenic purpura. In addition, it offers Libtayo for metastatic cutaneous squamous cell carcinoma; Jevtana and Taxotere taxane for cancers; Eloxatin for colon cancer; Thymoglobulin, an immunosuppressive and immunomodulating agent; Mozobil for hematologic malignancies; and Zaltrap for metastatic colorectal cancer. Further, it provides Lantus, Toujeo, Apidra, and Insuman insulins; Amaryl sulfonylurea; Adlyxin/Lyxumia, a GLP-1 receptor agonist; Soliqua 100/33/Suliqua, an insulin glargine and lixisenatide combination to treat diabetes; Admelog/Insulin lispro insulin; Praluent, a cholesterol-lowering drug; and Multaq, an anti-arrhythmic drug. Additionally, it offers Plavix for atherothrombotic conditions; Lovenox for the prophylaxis, venous thromboembolism, and acute coronary syndrome; Aprovel and CoAprovel anti-hypertensives; Renagel and Renvela for patients undergoing dialysis; Synvisc and Synvisc-One viscosupplements for osteoarthritis; Stilnox for insomnia; Allegra for seasonal allergic rhinitis and uncomplicated hives; and Depakine for epilepsy. It also provides generic products; and products for allergy, cough, cold, pain, nutrition, digestion, pediatrics, influenza, meningitis, travel, and endemic vaccines; and adult and adolescent boosters. Sanofi has collaborations with Verily Life Sciences LLC; Happify Health; GlaxoSmithKline Plc; Kymera Therapeutics; Parkinson's Foundation, Inc.; and Nurix Therapeutics, Inc. The company was formerly known as Sanofi-Aventis. Sanofi was incorporated in 1994 and is headquartered in Paris, France.
La calificación ISS Governance QuickScore de Sanofi a partir del 3 de diciembre de 2020 es 5. Las puntuaciones principales son Auditoría: 3; Junta: 5; Derechos del accionista: 4; Compensación: 7.